NDC 70518-4502-00 - Lidocaine
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70518-4502
- Requested NDC
- 70518-4502-00
- Package NDCs from labels
- 70518-4502-0, 70518-4502-00
- Manufacturer
- REMEDYREPACK INC.
- Effective date
- 2026-10-29
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| LIDOCAINE PATCH 5% | REMEDYREPACK INC. | 2026-10-29 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70518-4502-0 | Lidocaine | 30 in 1 CARTON | PATCH | 30 | 1 | |
| 70518-4502-0 | Lidocaine | 0.7 g in 1 POUCH | PATCH | 0.7 | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Family Wellness HEMORRHOID | GLYCERIN, PETROLATUM, PHENYLEPHRINE HCL, PRAMOXINE HCL | FAMILY DOLLAR (Family Wellness) | 16ceb129-5c0a-428a-a867-cfbbb08bb62a | 2026-10-26 | Warnings | PDC6A3C0OX |
| Nuvexa | LIDOCAINE 2.8 | Oncora Pharma, LLC | 9cb9b056-653b-4fa7-8ecf-110c84c513da | 2026-10-26 | Warnings | 98PI200987 |
| Optase | GLYCERIN | Scope Health Inc | d81c1a4f-87b0-ee8c-e053-2995a90af9e5 | 2026-10-25 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 9e96976b-2990-79e0-e053-2995a90a0f29 | 2026-10-25 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 376e0289-28e9-e87f-e063-6294a90a3b04 | 2026-10-25 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | f452a2c4-c869-7bf5-e053-2995a90ac1a0 | 2026-10-25 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 10c3e31d-779d-8ff6-e063-6294a90acd39 | 2026-10-25 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 86c14327-ffc7-806e-e053-2991aa0aaf92 | 2026-10-25 | Warnings | PDC6A3C0OX |
| iShanCare PAIN RELIEF Gel-Patch | LIDOCARINE | Shenzhen Ishan Technology Co., Ltd | 29739289-42b6-0047-e063-6394a90ad931 | 2026-10-23 | Warnings | 98PI200987 |
| Clear Eyes Maximum Redness Relief | NAPHAZOLINE HYDROCHLORIDE AND GLYCERIN | Prestige Brands Holdings, Inc. | c3b0e344-68dd-4c35-bf46-744e612a5b15 | 2026-10-23 | Warnings | PDC6A3C0OX |
| Clear Eyes Triple Relief | POLYVINYL ALCOHOL AND POVIDONE AND TETRAHYDROZOLINE HYDROCHLORIDE | Prestige Brands Holdings, Inc. | 1269a1a6-843d-4d08-bb3c-c1f3d2e7080d | 2026-10-23 | Warnings | 532B59J990 |
| Spravex | SPRAVEX | Oncora Pharma, LLC | 57fd8178-0d7d-4dfa-8669-26908c4acf80 | 2026-10-23 | Warnings | 98PI200987 |
| NO MORE PE | LIDOCAINE | MUHAMMAD SABIH JAVED | 738fb047-fdfa-4916-9c0c-010951a70f70 | 2026-10-22 | Warnings | 98PI200987 |
| Doctor Butlers Hemorrhoid and Fissure External Pain Formula | LIDOCAINE 5% | Beyond Health, P.A. | d92f22a7-c0b5-d8b8-e053-2a95a90a2376 | 2026-10-22 | Warnings | 98PI200987 |
| Dr Butlers Hemorrhoid and Fissure PF | LIDOCAINE 4.00, PHENYLEPHRINE HYDROCHLORIDE 0.25 | Beyond Health P.A. | f526199e-5c9e-7a3c-e053-2a95a90aa98e | 2026-10-22 | Warnings | 98PI200987 |
| Urea 10% | UREA 10% | Krewe Pharma, LLC | 4242207b-d3c4-4ae6-9faa-b30d4492057c | 2026-10-22 | Warnings | 8W8T17847W |
| Lidoflect | LIDOCAINE 4% | V2 Pharma LLC | 0eadd867-5ce9-4a9a-acd6-6ef857e6e518 | 2026-10-22 | Warnings | 98PI200987 |
| Lidocaine 4% Patch | LIDOCAINE 4% | Blue Heron Pharmaceuticals LLC | d2a9853a-184a-4134-9ec1-bc21f8dca63c | 2026-10-21 | Warnings | 98PI200987 |
| Trubrexa | LIDOCAINE AND CAPSAICIN | Preferred Pharmaceuticals Inc. | 7a671ac6-5744-4e87-b1bd-434ca0a86e6d | 2026-10-21 | Warnings | 98PI200987 |
| Urevia 10 | UREVIA 10 | Blue Heron Pharmaceuticals, LLC | 64338ed8-a73b-4d85-bd96-9d426a6db843 | 2026-10-21 | Warnings, Adverse reactions | 8W8T17847W |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.